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OBJECTIVE— We examined the effect of intrauterine diabetes exposure (IDE) on the inci-
dence of diabetic end-stage renal disease (ESRD) in Pima Indians with type 2 diabetes.
RESEARCH DESIGN AND METHODS— Individuals were followed from their first
diabetic examination until December 2006, death, ESRD, or age of 45 years.
RESULTS— Among the 1,850 diabetic participants, 102 had IDE. ESRD developed in 57, 5
of whom had IDE. Cumulative incidence of ESRD by age 45 was 19.3% in participants with IDE
and 5.1% in those without; the age- and sex-adjusted incidence rate ratio was 4.12 (95% CI
1.54–11.02). After additional adjustment for age at diabetes onset, ESRD incidence was similar
in the two groups (incidence rate ratio 1.38, 95% CI 0.45–4.24).
CONCLUSIONS— IDE increases the age- and sex-adjusted incidence of ESRD fourfold in
young adults with type 2 diabetes, mediated primarily by the earlier onset of type 2 diabetes in
those with IDE.
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The intrauterine environment plays acentral role in fetal development,and an adverse environment may
enhance the risk of chronic diseases in the
offspring (1–4). We examined the effect
of intrauterine diabetes exposure (IDE)
on incidence of diabetic end-stage renal
disease (ESRD) in Pima Indians with type
2 diabetes.
RESEARCH DESIGN AND
METHODS— Between 1965 and
2007, Pima Indians from the Gila River
Indian Community participated in a lon-
gitudinal diabetes study. Each member of
the community 5 years old was invited
to have a research examination every 2
years that included a 75-g oral glucose
tolerance test. In addition, many pregnant
women also had a 75-g oral glucose toler-
ance test in the third trimester. Diabetes
was defined by a 2-h postload plasma glu-
cose concentration 11.1 mmol/l (200
mg/dl), or by a clinical diagnosis between
examinations. IDE was considered
present if diabetes was diagnosed in the
mother before the child’s birth.
Diabetic ESRD was defined as the ini-
tiation of renal replacement therapy or
death from diabetic nephropathy and was
ascertained independently of the research
examinations. Cause of ESRD in those re-
ceiving renal replacement therapy was de-
termined from clinical records. Death was
attributed to diabetic nephropathy if
ICD-9 code 250.4 was specified as the un-
derlying cause. The study population in-
cluded diabetic subjects aged 5–45 years
who attended research examinations and
resided in the community. The longitudi-
nal study was approved by the review
board of the National Institute of Diabetes
and Digestive and Kidney Diseases. Each
participant gave informed consent or
assent.
Statistical analysis
Clinical features at baseline were com-
pared by IDE with ANCOVA for contin-
uous variables or Mantel-Haenszel 2 for
categorical variables stratified by sex.
Variables with nonnormal distributions
were analyzed with the Kruskal-Wallis
test.
Incidence of ESRD was computed
and events and person-years of follow-up
were stratified in a time-dependent fash-
ion by decades of age. Individuals were
followed from their first diabetic exami-
nation after 1 January 1965 until 31 De-
cember 2006, death, onset of ESRD, or
age of 45 years, whichever came first. In-
dividuals aged 45 years were not in-
cluded, because few people whose IDE
could be determined were followed past
45 years of age. Unadjusted cumulative
incidence of ESRD in diabetic subjects,
stratified by IDE, was estimated by the
Kaplan-Meier product-limit method ei-
ther as a function of age or duration of
diabetes. When calculated by age, sub-
jects entered at the diagnosis of diabetes,
and the Kaplan-Meier method was modi-
fied for left-truncated data (5). Differ-
ences in cumulative incidence were
assessed by the log-rank test. Age- and
sex-adjusted incidence rates of ESRD
were standardized to the 1985 Pima In-
dian population, and rate ratios were
computed from these age- and sex-
adjusted rates. Incidence rate ratios ad-
justed for age, sex, and age at onset of
diabetes were computed by Mantel-
Haenszel stratification. The proportion of
incident ESRD due to IDE in the diabetic
population was computed as the differ-
ence in age-and sex-adjusted incidence of
ESRD in the total diabetic population and
in the diabetic population without IDE
divided by the age- and sex-adjusted in-
cidence in the total diabetic population.
RESULTS— Among the 1,850 dia-
betic subjects, 102 (5.5%) were offspring
of diabetic mothers. Median follow-up
from the first diabetic examination was
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7.1 years (interquartile range 3.2–12.5
years). Those exposed to diabetes in utero
were significantly younger at baseline
than those unexposed (17.5 vs. 34.2
years; P  0.0001), owing to the earlier
onset of diabetes characteristic of this
exposure, and had lower BMI, blood
pressure, and serum cholesterol concen-
tration. At the end of follow-up, median
age of the unexposed participants re-
mained significantly greater than in those
with IDE (26.7 vs. 45.0 years; P 
0.0001), but the median duration of dia-
betes was similar (7.6 vs. 8.8 years; P 
0.22).
ESRD developed in 57 participants, 5
of whom were exposed to diabetes in
utero. Cumulative incidence of ESRD by
age was higher in participants with IDE
than in those without (P 0.001) but was
equivalent in the two groups when exam-
ined by diabetes duration (P 0.79) (Fig.
1). Unadjusted incidence was 5.61 cases/
1,000 person-years in participants with
IDE and 3.52 cases/1,000 person-years in
those without. Age- and sex-adjusted in-
cidence in those with IDE was 4.12 (95%
CI 1.54–11.02) times that of the unex-
posed. After additional adjustment for age
at diabetes onset, ESRD incidence was
similar in the two groups (incidence rate
ratio 1.38, 95% CI  0.45–4.24). The
proportion of diabetic ESRD attributable
to IDE in the diabetic population aged
45 years was 18.9%.
CONCLUSIONS— Exposure to IDE
was associated with a fourfold increase in
the incidence of ESRD in young adults
with type 2 diabetes when adjusted for
age and sex. This effect was explained
largely by their earlier age at onset of dia-
betes. To our knowledge, this study is the
first to link IDE to an earlier onset of
ESRD.
Recent improvements in diabetes
management has reduced the overall in-
cidence of diabetic ESRD in some popu-
lations (6,7). Less effective therapeutic
management of youth and young adults
with type 2 diabetes (8), however, may
limit these beneficial trends in younger
people (6). In the present study, estimates
of the population attributable risk of
ESRD ascribed to IDE suggest that inter-
ventions that delay diabetes onset in
women until after the child-bearing years
could ultimately eliminate 18.9% of the
ESRD that would occur before the age of
45 years in the children of these women.
IDE exposure increased nearly four-
fold in Pima Indians between 1967 and
1996, and the prevalence of diabetes in
youth related to this exposure doubled
during the same period (9). Nevertheless,
because type 2 diabetes in youth is a re-
cent phenomenon, even in the Pima Indi-
ans, the number of cases of ESRD
attributable to IDE in the present study
was small. The effect of this exposure,
however, was large, and trends with re-
spect to diabetes and its complications in
this population have been a reliable har-
binger for trends in other populations.
Implementation of appropriate behav-
ioral interventions to prevent or delay di-
abetes in women of child-bearing age may
be an effective long-term strategy to re-
duce the increasing incidence of diabetic
ESRD in young adults.
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